Dario Scaramuzzi

Dario Scaramuzzi is a highly qualified professional with a diverse educational background and extensive experience in the healthcare and pharmaceutical industry.

He obtained a Degree in Pharmacy from Università degli Studi di Bari, further enhancing his expertise with a Postdegree in Regulatory Affairs from Università degli Studi di Pavia.

His academic pursuits also include a specialized study on the transmission, response, and control of Ebola at the London School of Hygiene and Tropical Medicine, University of London.

Throughout his career, Dario has held various significant roles in renowned organizations, showcasing his versatility and commitment to the field.

Currently serving as a Site Engagement Manager at UCB, Dario's experience spans across different areas, reflecting his adaptability and leadership skills.

Previously, he contributed his expertise as a Pro-bono Partners Engagement & Capacity Development Manager at R-Evolution Worldwide Community Interest Company, highlighting his dedication to social impact initiatives.

Dario's extensive professional background includes roles such as Senior Clinical Research Associate Consultant at FHI 360, Senior CRA Consultant at Syneos Health, PSI CRO AG, Novella Clinical, Quintiles, ICON plc, and Amantec GmbH, as well as CRA Consultant at Phidea Marvin.

His rich experience in clinical research and pharmaceutical consulting positions him as a seasoned expert in the industry, capable of handling diverse challenges with precision and expertise.